WESTLAKE VILLAGE, Calif.–(BUSINESS WIRE)–Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced that Bradley Burnam, Chief Executive Officer, will deliver a company presentation as part of the Jefferies Global Healthcare Conference in London. Presentation details are as follows: Date: Monday, November 16, 2026 Time: 10:30 AM – 10:55 AM ET (3:30 PM – 3:55 PM GMT) The Company will

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.